MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.mtbio.2026.103296

Медицинская библиотека · Materials today. Bio · 2026

ROS-responsive nanocarriers for the delivery of atorvastatin in ischemic MCAO rats promoting neuroprotection.

Nagareddy Raveena, Sundaram Aravindkumar, Kim Ja-Hae, Kim Ji Hye, Vasvani Shyam, Kweon Seho, Park In-Kyu, Jeong Yong Yeon, Choi Kang-Ho

СтатьяПеревод в очереди

Аннотация

Ischemic stroke remains a major global public health burden, ranking among the leading causes of long-term neurological disability and mortality. Despite advances in acute care, drug delivery to injured brain tissue is hindered by the poor permeability of the blood-brain barrier (BBB), a challenge exacerbated by excess reactive oxygen species (ROS), particularly hydrogen peroxide (H2O2), produced during ischemia-reperfusion. This oxidative surge also offers an opportunity to design ROS-responsive, site-specific therapeutic delivery systems. Therefore, this study aims to develop PEGylated thioketal-based nanocarriers (PTC) loaded with atorvastatin, a statin with both neuroprotective and anti-inflammatory properties. The thioketal linker in PTC undergoes selective cleavage by H2O2, enabling the nanocarrier to function as both a smart drug delivery vehicle and an ROS scavenger. In vitro experiments using oxygen-glucose deprivation-treated BV-2 microglial cells demonstrated that PTC-statin significantly lowered intracellular ROS, inhibited lipid peroxidation, and reduced inflammatory cytokine release. In vivo, intravenous PTC-statin administration in a rat middle cerebral artery occlusion model significantly reduced infarct size, improved motor coordination (p = 0.032), and enhanced neurological outcomes (p = 0.002), with MRI confirming infarct reduction as early as day 5 (p = 0.02). Molecular and histological analyses further revealed restored BBB integrity, reduced neuronal apoptosis, and promoted neurogenesis. Overall, these findings highlight PTC-statin as a precision nanomedicine that enables site-specific, ROS-triggered drug release and mitigates oxidative damage, offering a targeted therapeutic strategy for ischemic stroke recovery.

Для цитирования: Nagareddy Raveena, Sundaram Aravindkumar, Kim Ja-Hae, Kim Ji Hye, Vasvani Shyam, Kweon Seho, Park In-Kyu, Jeong Yong Yeon, Choi Kang-Ho. ROS-responsive nanocarriers for the delivery of atorvastatin in ischemic MCAO rats promoting neuroprotection.. Materials today. Bio. 2026. DOI: 10.1016/j.mtbio.2026.103296.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.